MYC and chronic myelogenous leukemia, BCR-ABL1 positive: However, a rare recurrent translocation t(3;8) (q26.2;q24), causing MECOM-MYC rearrangement, has been reported to be associated with therapy-related and relapsed AML as well as AML transformed from Ph+ CML [609, 610].